Laparoscopic Power Morcellators Market, By Application (Hysterectomy, Myomectomy, and Others), By End User (Hospitals and Clinics and Surgical Centers), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : May 2024

Code : CMI4905

Pages :196

Formats :

Excel and PDF

Industry : Medical Devices

Laparoscopic Power Morcellators Market Size and Trends

Global laparoscopic power morcellators market is estimated to be valued at USD 137.4 Mn in 2024 and is expected to reach USD 225.6 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

Laparoscopic Power Morcellators Market Key Factors

To learn more about this report, request sample copy

The global laparoscopic power morcellators market is expected to witness positive growth over the forecast period due to increasing gynecological procedures worldwide and rising obese population. Laparoscopic power morcellators are used in laparoscopic procedures to cut tissue or organs into smaller pieces so that they can be easily removed through smaller incisions. These devices help in minimally invasive procedures and enable faster recovery for patients.

Market Driver – Increasing prevalence of Uterine Leiomyomata (UL) in women

Increasing prevalence of Uterine Leiomyomata (UL) in women is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period. Increasing prevalence of uterine fibroids in women; will in turn increase the adoption of laparoscopic power morcellators which is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period. For instance, according to an article published in August 2021, the prevalence and burden of symptomatic uterine leiomyomata which is also called as fibroids and benign tumors of the uterus among women was approximately one in 20 or 5% or 13.6 million women globally.

/p>Market Driver – Increasing Product Approvals by Regulatory Authorities

Companies are focused on developing new laparoscopic power morcellators with 510 (k) product clearance based on new regulatory guidelines from the regulatory authorities such as U.S., European Union etc., which is expected to drive the growth of the global laparoscopic power morcellators market over the forecast period. For instance, on February 3, 2021, Olympus America, a medical device company indicated that it supported the U.S. Food and Drug Administration (FDA) published guidance recommendations suggesting that laparoscopic power morcellators in gynecological procedures must be performed using an approved containment device. Olympus Corporation is now the sole manufacturer having a 510(k)-cleared containment laparoscopic power morcellation device in the U.S.